A drug rollout that officials hailed as a demonstration that the UK was still a “science superpower,” has reached only a ...
Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...
Inflammation may help explain why heart attacks and strokes occur in women who do not have any of the usual risk factors, researchers say. Women who suffer heart attacks or strokes often have none of ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Sept. 4, 2025 /PRNewswire/ -- According to DataM Intelligence, the RNAi technology market ...
85% of patients on Leqvio plus individually optimized lipid-lowering therapy (LLT) achieved LDL-C targets within 90 days vs. 31% of patients on placebo plus LLT 1 Patients on Leqvio plus LLT were 43% ...
More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when ...
A staggering 28 million adults in the United States have high cholesterol, meaning they have too many lipids (fats) in their blood. That number, from the Centers for Disease Control and Prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback